Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$11.12 -0.24 (-2.11%)
As of: Oct 21, 2026 · 3:05 PM EDT

Monte Rosa Therapeutics (GLUE) Current Assets (2020 - 2026)

Updated

Monte Rosa Therapeutics (GLUE) reported Current Assets of $631.41 million for Q2 2026, up 110.8% from $299.47 million a year earlier but down 6.8% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Current Assets (2020 - 2026) Analysis & Trends

At the end of FY2025, Monte Rosa Therapeutics posted Current Assets of $393.19 million, up 4.2% from FY2024.

  • Current Assets has a five-year compound annual growth rate of 55.3% (FY2020 to FY2025).
  • By year, Current Assets came in at $377.44 million in FY2024 (+59.8%), $236.21 million in FY2023 (-14.4%), $275.89 million in FY2022 (-20.9%) and $348.67 million in FY2021 (+699.9%).
  • Five-year quarterly Current Assets spans a low of $182.91 million in Q3 2023 and a high of $677.55 million in Q1 2026.
  • Year over year, Current Assets has now increased in each of the last nine quarters, with growth averaging 56.3% over the last eight quarters.
  • The high point for year-over-year Current Assets in five years was Q4 2021 (growth of 699.9%); the low point was Q3 2023 (a decline of 38.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $677.55 million (Q1 2026), $393.19 million (Q4 2025) and $401.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,136.68 Bn 1,105.26 Bn 19.71 Bn 64.67 Bn
2 Johnson & Johnson 617.43 Bn 535.95 Bn 17.26 Bn 59.77 Bn
3 AbbVie 501.53 Bn 474.64 Bn 12.70 Bn 33.67 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn 36.68 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn 27.35 Bn
6 Astrazeneca 260.75 Bn 234.43 Bn 12.86 Bn 27.97 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn 34.96 Bn
8 Gilead Sciences 191.10 Bn 165.30 Bn 6.22 Bn 13.95 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn 41.36 Bn
10 Monte Rosa Therapeutics 1.13 Bn 540.26 Mn - 631.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 631.41 Mn
Mar 31, 2026 677.55 Mn
Dec 31, 2025 393.19 Mn
Sep 30, 2025 401.82 Mn
Jun 30, 2025 299.47 Mn
Mar 31, 2025 332.28 Mn
Dec 31, 2024 377.44 Mn
Sep 30, 2024 251.21 Mn
Jun 30, 2024 277.90 Mn
Mar 31, 2024 199.04 Mn
Dec 31, 2023 236.21 Mn
Sep 30, 2023 182.91 Mn
Jun 30, 2023 208.10 Mn
Mar 31, 2023 240.56 Mn
Dec 31, 2022 275.89 Mn
Sep 30, 2022 295.24 Mn
Jun 30, 2022 297.05 Mn
Mar 31, 2022 320.37 Mn
Dec 31, 2021 348.67 Mn
Sep 30, 2021 370.52 Mn
API Access

Monte Rosa Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=GLUE&period=max&api_key=YOUR_API_KEY